Private Markets, Angel and Secondary Investing, Sacra

Sacra

Private Markets, Angel and Secondary Investing

Bringing transparency to private markets so investors, founders, and employees can build on conviction. Sacra delivers deeply researched insights on the private companies shaping tomorrow's markets. By surfacing the data, context, and operator perspective that are missing from private markets today, we help secondary buyers and sellers price equity accurately and unlock liquidity for the people building these businesses.

Private Capital Markets

Isomorphic Labs / Private Capital Markets

<ul><li>Isomorphic Labs raised a $2.1B Series B in May 2026 led by Thrive Capital, with participation from Alphabet, GV, MGX, Temasek, CapitalG, and the UK Sovereign AI Fund.</li><li>Isomorphic says this process can compress months of physical iteration into two to four days of computational design, followed by targeted laboratory validation.</li><li>The $2.1B Series B, appointment of a chief medical officer, and establishment of a Cambridge, Massachusetts presence indicate this shift.</li></ul>

Isomorphic Labs raised a $2.1B Series B in May 2026 led by Thrive Capital, with participation from Alphabet, GV, MGX, Temasek, CapitalG, and the UK Sovereign AI Fund.Isomorphic says this process can compress months of physical iteration into two to four days of computational design, followed by targeted laboratory validation.The $2.1B Series B, appointment of a chief medical officer, and establishment of a Cambridge, Massachusetts presence indicate this shift.

United Kingdom

AI-first drug discovery platform that applies protein-structure prediction and generative models to design therapeutic candidates

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Isomorphic Labs (LABS GB)

Primer: Isomorphic Labs - 30 Sep 2026

AI-first drug discovery platform that applies protein-structure prediction and generative models to design therapeutic candidates

Sacra

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)